News
Southcoast Behavioral Health Expands Services and Capacity
Southcoast Behavioral Health today reinforced its strong commitment to the communities it serves through the addition of a dedicated child and adolescent behavioral health program, expanding the
Clovis Oncology and Evergreen Theragnostics Initiate Development and Manufacturing Services Agreement for Actinium-225-Labeled FAP-2286
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the initiation of a development, manufacturing, and services agreement with Evergreen Theragnostics to develop actinium-225-labeled-FAP-2286 (22
DGAP-News: National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
DGAP-News: US-amerikanisches National Comprehensive Cancer Network(R) stuft Monjuvi(R) (Tafasitamab-cxix) in seinen Leitlinien als bevorzugte Behandlungsmethode für B-Zell-Lymphome ein
Poxel to Report Financial Results for Full Year 2021 and Host Webcast Call on March 22, 2022
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Valbiotis Publishes Its 2021 Annual Report
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases
Premier Inc. Named One of the 2022 World’s Most Ethical Companies® by Ethisphere® for 15th Consecutive Year
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been recognized by Ethisphere®, a global leader in defining and advancing the standards of ethical
Newron Announces 2021 Financial Results and Provides Outlook for 2022
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral
DGAP-News: Newron announces 2021 financial results and provides outlook for 2022
DGAP-News: Newron gibt Geschäftsergebnisse 2021 und Ausblick 2022 bekannt
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 250th unipolar depression patient has been implanted in the RECOVER clinical study, “A P
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended
Pfizer Completes Acquisition of Arena Pharmaceuticals
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several
ICON plc to Webcast Analyst Day Meeting
ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will provide a live webcast of its Analyst Day meeting which will take
DGAP-News: Invitation to MorphoSys' Full Year Results 2021 Conference Call on March 17, 2022
DGAP-News: Einladung zu MorphoSys' Telefonkonferenz am 17. März 2022 zu den Ergebnissen des Geschäftsjahres 2021
AEVIS VICTORIA SA sells its participation in Medgate to Otto Group
AEVIS VICTORIA SA verkauft Medgate-Beteiligung an Otto Group
DGAP-Adhoc: Ad hoc: MorphoSys AG reports non-cash impairment charge of € 231 million on goodwill after consolidation of research and discovery functions; corresponding increase of Group operating expenses in 2021
DGAP-Adhoc: Ad hoc: MorphoSys AG meldet nicht zahlungswirksame Wertminderung des Geschäfts- oder Firmenwertes von 231 Mio. € nach F&E Konsolidierung; entsprechende Erhöhung des operativen Konzernaufwands in 2021
AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year
AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Susan Salka, its President and Chief Executive
Simulations Plus Releases MembranePlus 3.0
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced it has
PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company today announced that its majority-owned digital health subsidiary Veris Health (“Veris”) has
Agilent Announces the 2022 Darlene Solomon Award Presented to Grenoble Alpes University Hospital Scientist Dr. Federica Fiorini
Agilent Technologies Inc. (NYSE: A) today announced that the recipient of the 2022 Darlene Solomon Award is Federica Fiorini, Ph.D., a research associate studying metabolomics at the Institute of
IMV Inc. to Announce Fourth Quarter and Fiscal Year 2021 Results and Host a Conference Call and Webcast on March 17, 2022
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today